WHETHER CHIDAMIDE IMPROVES THE RESPONSE TO CISPLATIN IN FIRST-LINE TREATMENT OF METASTATIC TRIPLE-NEGATIVE BREAST CANCER

被引：0

作者：

Zhang, Jian ^{[1
]}

Hu, Xichun ^{[1
]}

Meng, Yanchun ^{[1
]}

Jin, Juan ^{[1
]}

Gong, Chengcheng ^{[1
]}

Miao, Haitao ^{[1
]}

Tao, Zhonghua ^{[1
]}

Li, Ting ^{[1
]}

Cao, Jun ^{[1
]}

Wang, Leiping ^{[1
]}

Wang, Biyun ^{[1
]}

Hu, Xichun ^{[1
]}

机构：

[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China

来源：

BREAST | 2021年 / 59卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PO56

引用

页码：S46 / S46

页数：1

共 50 条

[1] Ixabepilone Alone or With Cetuximab as First-Line Treatment for Advanced/Metastatic Triple-Negative Breast Cancer
Tredan, Olivier
Campone, Mario
Jassem, Jacek
Vyzula, Rostislav
Coudert, Bruno
Pacilio, Carmen
Prausova, Jana
Hardy-Bessard, Anne-Claire
Arance, Ana
Mukhopadhyay, Pralay
Aloe, Alessandra
Roche, Henri
CLINICAL BREAST CANCER, 2015, 15 (01) : 8 - 15
[2] Docetaxel-cisplatin might be superior to docetaxel-capecitabine in the first-line treatment of metastatic triple-negative breast cancer
Fan, Y.
Xu, B. H.
Yuan, P.
Ma, F.
Wang, J. Y.
Ding, X. Y.
Zhang, P.
Li, Q.
Cai, R. G.
ANNALS OF ONCOLOGY, 2013, 24 (05) : 1219 - 1225
[3] Phase II study of chidamide in combination with cisplatin in patients with metastatic triple-negative breast cancer
Meng, Yanchun
Jin, Juan
Gong, Chengcheng
Miao, Haitao
Tao, Zhonghua
Li, Ting
Cao, Jun
Wang, Leiping
Wang, Biyun
Zhang, Jian
Hu, Xichun
ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (11) : 11255 - 11264
[4] Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial
Montagna, Emilia
Bagnardi, Vincenzo
Cancello, Giuseppe
Sangalli, Claudia
Pagan, Eleonora
Iorfida, Monica
Mazza, Manuelita
Mazzarol, Giovanni
Dellapasqua, Silvia
Munzone, Elisabetta
Goldhirsch, Aaron
Colleoni, Marco
BREAST CARE, 2018, 13 (03) : 177 - 181
[5] Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple negative metastatic breast cancer
Zhang, Jian
Wang, Leiping
Wang, Zhonghua
Wang, Biyun
Cao, Jun
Lv, Fangfang
Zhang, Sheng
Shao, Zhimin
Hu, Xichun
ONCOTARGET, 2017, 8 (45) : 79527 - 79536
[6] Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysis
Shi, Mingqiang
Li, Zhoujuan
Shen, Guoshuang
Wang, Tianzhuo
Li, Jinming
Wang, Miaozhou
Liu, Zhen
Zhao, Fuxing
Ren, Dengfeng
Zhao, Jiuda
CANCER PATHOGENESIS AND THERAPY, 2024, 2 (02): : 81 - 90
[7] Pembrolizumab plus chemotherapy for first-line treatment of advanced triple-negative breast cancer
Haiderali, Amin
Huang, Min
Pan, Wilbur
Akers, Katherine G.
Maciel, Dylan
Frederickson, Andrew M.
FUTURE ONCOLOGY, 2024, 20 (22) : 1587 - 1600
[8] A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer
Wang, Biyun
Sun, Tao
Zhao, Yannan
Wang, Shusen
Zhang, Jian
Wang, Zhonghua
Teng, Yue-E
Cai, Li
Yan, Min
Wang, Xiaojia
Jiang, Zefei
Pan, Yueyin
Luo, Jianfeng
Shao, Zhimin
Wu, Jiong
Guo, Xiaomao
Hu, Xichun
NATURE COMMUNICATIONS, 2022, 13 (01)
[9] A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer
Biyun Wang
Tao Sun
Yannan Zhao
Shusen Wang
Jian Zhang
Zhonghua Wang
Yue-E Teng
Li Cai
Min Yan
Xiaojia Wang
Zefei Jiang
Yueyin Pan
Jianfeng Luo
Zhimin Shao
Jiong Wu
Xiaomao Guo
Xichun Hu
Nature Communications, 13
[10] Cisplatin and gemcitabine as the first line therapy in metastatic triple negative breast cancer
Zhang, Jian
Wang, Zhonghua
Hu, Xichun
Wang, Biyun
Wang, Leiping
Yang, Wentao
Liu, Yang
Liu, Guangyu
Di, Genhong
Hu, Zhen
Wu, Jiong
Shao, Zhimin
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (01) : 204 - 211

← 1 2 3 4 5 →